These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19352366)

  • 61. Anticancer drug discovery and development.
    Colotta F
    Adv Exp Med Biol; 2008; 610():19-42. PubMed ID: 18593013
    [No Abstract]   [Full Text] [Related]  

  • 62. Antibody fragments for controlled delivery of therapeutic agents.
    Verhoeyen ME; van der Logt CP; Beggs TS; Davis PJ
    Biochem Soc Trans; 1995 Nov; 23(4):1067-73. PubMed ID: 8654683
    [No Abstract]   [Full Text] [Related]  

  • 63. Biotechnology's metamorphosis into a drug discovery industry.
    Drews J
    Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258
    [No Abstract]   [Full Text] [Related]  

  • 64. Trends in antimicrobial drug development: implications for the future.
    Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
    Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stategic trends in the drug industry.
    Drews J
    Drug Discov Today; 2003 May; 8(9):411-20. PubMed ID: 12706659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Commentary: contribution of pathology to drug research and development in the next decade.
    Harleman JH
    Toxicol Pathol; 1999; 27(4):479-80. PubMed ID: 10485834
    [No Abstract]   [Full Text] [Related]  

  • 67. New economics of the pharmaceutical supply chain.
    Yost RD
    Am J Health Syst Pharm; 2005 Mar; 62(5):525-6. PubMed ID: 15745917
    [No Abstract]   [Full Text] [Related]  

  • 68. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 69. Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays.
    Golay J; Introna M
    Arch Biochem Biophys; 2012 Oct; 526(2):146-53. PubMed ID: 22387378
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Product innovation in the pharmaceutical sector. IV. Internationalization and technologic innovation].
    Cavara C
    Boll Chim Farm; 1991 Dec; 130(11):458-67. PubMed ID: 1809300
    [No Abstract]   [Full Text] [Related]  

  • 71. Emerging unscathed?
    Gershell LJ; Miller TA
    Nat Rev Drug Discov; 2002 Sep; 1(9):739. PubMed ID: 12216577
    [No Abstract]   [Full Text] [Related]  

  • 72. Interview with John Patton.
    Patton JS
    Ther Deliv; 2010 Sep; 1(3):375-81. PubMed ID: 22816140
    [No Abstract]   [Full Text] [Related]  

  • 73. Lead generation--enhancing the success of drug discovery by investing in the hit to lead process.
    Alanine A; Nettekoven M; Roberts E; Thomas AW
    Comb Chem High Throughput Screen; 2003 Feb; 6(1):51-66. PubMed ID: 12570752
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New drug development in the United States from 1963 to 1990.
    DiMasi JA; Bryant NR; Lasagna L
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):471-86. PubMed ID: 1934860
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmaceutical Technology Conference--12th International Meeting. Problems and problem solving strategies in pharmaceutical formulation and drug delivery. 12-15 September 2004, Istanbul, Turkey.
    Steckel H
    IDrugs; 2004 Nov; 7(11):996-9. PubMed ID: 15551172
    [No Abstract]   [Full Text] [Related]  

  • 76. New drug development in the United States from 1963 to 1999.
    Dimasi JA
    Clin Pharmacol Ther; 2001 May; 69(5):286-96. PubMed ID: 11371996
    [No Abstract]   [Full Text] [Related]  

  • 77. PELLETS AND PELLETIZATION: EMERGING TRENDS IN THE PHARMA INDUSTRY.
    Zaman M; Saeed-Ul-Hassan S; Sarfraz RM; Batool N; Qureshi MJ; Akram MA; Munir S; Danish Z
    Acta Pol Pharm; 2016 Nov; 73(6):1415-1425. PubMed ID: 29634093
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transforming the work of early-stage drug discovery through bioprocess informatics.
    Holzman TF; Hebert EJ
    Drug Discov Today; 2005 Jan; 10(1):61-7. PubMed ID: 15676300
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 9th International drug delivery technologies & deal-making summit.
    Panzner S; Smith PL
    Expert Opin Drug Deliv; 2005 Jan; 2(1):189-90. PubMed ID: 16296745
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.